| Mr Stephen Reeves Dill, MD | |
|
6801 Airport Blvd # 11n, Mobile, AL 36608-3709 | |
| (251) 445-2412 | |
| (850) 981-1878 |
| Full Name | Mr Stephen Reeves Dill |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 6801 Airport Blvd # 11n, Mobile, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013921162 | NPI | - | NPPES |
| 51093021 | Other | AL | BLUE CROSS BLUE SHIELD AL |
| 5285145 | Other | AL | AETNA |
| 000093021 | Medicaid | AL | |
| 157220 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD12041 (Alabama) | Secondary |
| 207R00000X | Internal Medicine | 00012041 (Alabama) | Primary |
| Entity Name | Covenant Palliative Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710398136 PECOS PAC ID: 8921227398 Enrollment ID: O20150420000744 |
News Archive
Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp., providing Sorrento with a comprehensive technology platform to create a new generation of homogenous antibody drug conjugates with site-specific toxin conjugation and consistent drug-antibody ratios. With the close of the deal, Sorrento has issued an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders. Based on the closing share price on December 18, 2013, the transaction is valued at $11.3 million.
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated that ibrutinib, a kinase inhibitor, is significantly more effective than traditional chemotherapy with chlorambucil.
People with Alzheimer's disease are helping with a ground-breaking government-funded trial but with new sites recently opened in the South West more people are being asked to take part in the study led by academics from the Universities of Bristol, Cambridge, Queen's University Belfast and University College London, and hosted by North Bristol NHS Trust.
Iowa's largest public employees' union filed a complaint today with the state alleging Gov. Terry Branstad broke the law when he signed an executive order that allows state workers to voluntarily pay 20 percent of their health insurance premiums. The prohibitive practice complaint filed with the Iowa Public Employment Relations Board alleges state law bans Branstad from making unilateral changes to health insurance plans because they are collectively bargained, said Danny Homan, president Council 61 of the American Federation of State, County and Municipal Employees.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Stephen Reeves Dill, MD 6801 Airport Blvd 11th Floor, Mobile, AL 36608-3709 Ph: (251) 445-2412 | Mr Stephen Reeves Dill, MD 6801 Airport Blvd # 11n, Mobile, AL 36608-3709 Ph: (251) 445-2412 |
News Archive
Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp., providing Sorrento with a comprehensive technology platform to create a new generation of homogenous antibody drug conjugates with site-specific toxin conjugation and consistent drug-antibody ratios. With the close of the deal, Sorrento has issued an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders. Based on the closing share price on December 18, 2013, the transaction is valued at $11.3 million.
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated that ibrutinib, a kinase inhibitor, is significantly more effective than traditional chemotherapy with chlorambucil.
People with Alzheimer's disease are helping with a ground-breaking government-funded trial but with new sites recently opened in the South West more people are being asked to take part in the study led by academics from the Universities of Bristol, Cambridge, Queen's University Belfast and University College London, and hosted by North Bristol NHS Trust.
Iowa's largest public employees' union filed a complaint today with the state alleging Gov. Terry Branstad broke the law when he signed an executive order that allows state workers to voluntarily pay 20 percent of their health insurance premiums. The prohibitive practice complaint filed with the Iowa Public Employment Relations Board alleges state law bans Branstad from making unilateral changes to health insurance plans because they are collectively bargained, said Danny Homan, president Council 61 of the American Federation of State, County and Municipal Employees.
› Verified 6 days ago
Damian Joseph Collins, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Spring Hill Ave, Suite 100, Mobile, AL 36604 Phone: 251-435-1200 Fax: 251-435-6357 | |
Lenore Landers Pierce, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-639-5775 Fax: 251-631-3581 | |
Peter Chestnutt Coats, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6701 Airport Blvd, Suite A-101, Mobile, AL 36608 Phone: 251-633-8880 Fax: 251-634-4502 | |
Dr. Dale Scott Kirby Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Suite D-330, Mobile, AL 36608 Phone: 251-607-9797 Fax: 251-607-9761 | |
Sandeep Vidyadhar Bhadkamkar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-266-3580 Fax: 251-266-3581 | |
Reynaldo Rodriguez, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 Springhill Business Park, Mobile, AL 36608 Phone: 251-873-6192 Fax: 251-873-6193 |